Sensitivity of multiparametric MRI and targeted biopsy for detection of adverse pathologies (Cribriform gleason pattern 4 and intraductal carcinoma): Correlation of detected and missed prostate cancer foci with whole mount histopathology-Reference-Cited by-同舟云学术

Sensitivity of multiparametric MRI and targeted biopsy for detection of adverse pathologies (Cribriform gleason pattern 4 and intraductal carcinoma): Correlation of detected and missed prostate cancer foci with whole mount histopathology

Published:2022-10 Issue:10 Volume:40 Page:452.e1-452.e8
ISSN:1078-1439
Container-title:Urologic Oncology: Seminars and Original Investigations
language:en
Short-container-title:Urologic Oncology: Seminars and Original Investigations

Author:

Cai Qi,Costa Daniel N.,Metter Christopher K.,Goldberg Kenneth,Roehrborn Claus G.,Cadeddu Jeffrey,Pedrosa Ivan,Meng Xiaosong,Mostardeiro Thomaz R.,Shah Rajal B.^ORCID

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference30 articles.

1. Update of the standard operating procedure on the use of multiparametric magnetic resonance imaging for the diagnosis, staging and management of prostate cancer;Bjurlin;J Urol,2020

2. Multiparametric MRI for prostate cancer diagnosis: Current status and future directions;Stabile;Nat Rev Urol,2020

3. Prostate cancer: State of the art imaging and focal treatment;Woodrum;Clin Radiol,2017

4. Multifocality and prostate cancer detection by multiparametric magnetic resonance imaging: Correlation with whole-mount histopathology;Le;Eur Urol,2015

5. Outcome of Gleason 3 + 5 = 8 prostate cancer diagnosed on needle biopsy: Prognostic comparison with gleason 4 + 4 = 8;Harding-Jackson;J Urol,2016

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Histopathological evaluation and grading for prostate cancer: current issues and crucial aspects;Asian Journal of Andrology;2024-09-10

2. Comparison of Multiparametric MRI–targeted and Systematic Biopsies for Detection of Cribriform and Intraductal Carcinoma Prostate Cancer;Radiology;2024-07-01

3. Proposal for an optimised definition of adverse pathology (unfavourable histology) that predicts metastatic risk in prostatic adenocarcinoma independent of grade group and pathological stage;Histopathology;2024-06-03

4. Exploring the potential of ex-vivo 7-T magnetic resonance imaging on patients with clinically significant prostate cancer: visibility and size perspective;Prostate International;2024-06

5. Limitations of Prostate Biopsy in Detection of Cribriform and Intraductal Prostate Cancer;European Urology Focus;2023-09